MRI assessment of cardiac structure and function presented at ADA

New data was presented over the weekend at the American Diabetes Association’s 84th Scientific Sessions by our collaborators. The presented research, performed as a collaboration between The Institute of Aerospace Medicine, Profil, Novo Nordisk, and Antaros Medical, investigated the effects of a functionally selective insulin on cardiac structure and function in individuals with type 2 diabetes (T2D).

The study assessed vascular function and cardiac structure and function using magnetic resonance imaging (MRI). MRI enables non-invasive assessment of parameters such as left ventricular ejection fraction and left ventricular stroke volume, among others. The findings were presented as a poster.

Abstract title: Influence of the functionally selective insulin analog NN-965 vs. insulin glargine (IGla) on cardiac structure and function
Abstract number: 822-P
Authors: Jordan J, Gerlach D, Haraldsson H, Heise T, Herbrand T, Lyby K, Tank J, Nishimura E, Plum-Moerschel L, Thórisdóttir Ó, Johansson L
Poster presentation June 22, 12:30 – 13:30 (EST)

The American Diabetes Association (ADA)‘s Annual Scientific Sessions is the world’s largest diabetes meeting, and this year will take place from June 21-24 in Orlando, Florida as well as virtually.

Find the Scientific Programme here.

Share on Linkedin Share on Twitter